China’s Vaccine Congress Draws Pharmaceutical MNCs
This article was originally published in PharmAsia News
Executive Summary
More than 300 scientists and executives from pharmaceutical MNCs congregated at the recent First World Vaccine Congress held in Guangdong, China. Participants included top officials from the International Vaccine Institute of Korea, Baxter International, Intercell and GSK, reflecting overseas companies' optimism in the country's vaccine market. The event aimed to boost the internationalization of China's vaccine industry, speeding up changes in its production and biotechnology. Although major vaccine player Baxter has not started its vaccine business in China, it has been keeping a close eye on the country and analysts believe it will enter the market soon. Baxter considers China a high-priority international market, especially for vaccine products. (Click here for more - Chinese Language)